- document
-
de Vries, M. (author), Christianen, M. E.M.C. (author), Luthart, L. (author), de Vries, K. C. (author), Kolkman-Deurloo, I. K.K. (author), van den Dobbelsteen, J.J. (author)Prostate cancer patients with an enlarged prostate and/or excessive pubic arch interference (PAI) are generally considered non-eligible for high-dose-rate (HDR) brachytherapy (BT). Steerable needles have been developed to make these patients eligible again. This study aims to validate the dosimetric impact and performance of steerable needles...journal article 2024